Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Aimmune Therapeutics, Inc. kasuwar kasuwa

Matsayin kasuwancin jari na Aimmune Therapeutics, Inc. a yau da kuma tarihin ƙaddamar da Aimmune Therapeutics, Inc. daga farkon kasuwanci a AIMT hannun jari akan musayar jari.
Ƙara zuwa widget din
Ƙara zuwa widget din

Aimmune Therapeutics, Inc. girma

Yau kasuwa kasuwa na Aimmune Therapeutics, Inc. shine 2 256 700 160 US dollar.
+2 615 040 $ (+0.12%)
canji na strongn kudi tun jiya

Bayanin Aimmune Therapeutics, Inc. an karɓi iko daga manyan hanyoyin. Kuna iya gano Aimmune Therapeutics, Inc. capitalization na yau dangane da ciniki na wannan abin da aka ambata kan kasuwar musayar jari. Wannan shi ne bayanin tunani game da Aimmune Therapeutics, Inc. capitalization. Aimmune Therapeutics, Inc. capitalization = 2 256 700 160 dalar Amurka.

Aimmune Therapeutics, Inc. girma na kasuwanci

Yau yaudarar kasuwancin jari Aimmune Therapeutics, Inc. ya kai 103 658 US dollar.
-505 496 $ (-82.98%)
canjin karuwar kasuwancin tun jiya

Aimmune Therapeutics, Inc. girman ciniki yau - 103 658 dalar Amurka. Aimmune Therapeutics, Inc. ana kasuwanci dashi a shafukan yanar gizo na kasuwanci daban-daban. Aimmune Therapeutics, Inc. ciniki wanda aka gudanar kan musayar bayanan hannun jari a ainihin lokacin, muna nuna ƙimar ciniki ta yau da kullun Aimmune Therapeutics, Inc.. Aimmune Therapeutics, Inc. karuwanci ya girma ta $ 2 615 040.

Nuna:
To

Aimmune Therapeutics, Inc. kasuwar kasuwa

Aimmune Therapeutics, Inc. karfafan kasuwanni akan jadawali cikin shekaru. 0% a wata - wani canji a cikin kasuwar kasuwar Aimmune Therapeutics, Inc.. 0% a kowace shekara - wani canji a cikin kasuwar kasuwancin Aimmune Therapeutics, Inc.. Aimmune Therapeutics, Inc. karuwanci yana girma kowace rana a dalar Amurka.

Week Watan 3 months Shekara 3 shekaru

Aimmune Therapeutics, Inc. tarihin lalata

Kwanan Girma
Babban jari (kasuwannin kasuwa) shine kasuwa na kasuwa na kamfanonin da ke sayarwa akan musayar jari. Mahimmancin kasuwancin yana daidai da farashin hannun jari da yawa ta hanyar yawan kuɗi.
12/10/2020 2 256 700 160 $
09/10/2020 2 254 085 120 $
08/10/2020 2 251 143 424 $
07/10/2020 2 251 143 424 $
06/10/2020 2 250 489 600 $
05/10/2020 2 247 547 904 $
02/10/2020 2 245 913 344 $

Aimmune Therapeutics, Inc. tashar girma

Week Watan 3 months Shekara 3 shekaru

Aimmune Therapeutics, Inc. bayanan tarihi na tarihi

Kwanan Volume (24h)
Ƙaramar kasuwancin Aimmune Therapeutics, Inc. hannun jari shine yawan yawan ma'amaloli tare da hannun jari na AIMT da aka saya a lokacin da aka zaba.
12/10/2020 103 658 $
09/10/2020 609 154 $
08/10/2020 237 978 $
07/10/2020 589 166 $
06/10/2020 222 615 $
05/10/2020 71 201 $
02/10/2020 758 177 $

Aimmune Therapeutics, Inc. aikin mallaka a 12/10/2020 yayi daidai da 2 256 700 160 dalar Amurka. 09/10/2020 Aimmune Therapeutics, Inc. karfaffen kaya ya kai 2 254 085 120 Dalar Amurka. Babban tsarin kasuwancin Aimmune Therapeutics, Inc. a 08/10/2020 wanda aka kimanta zuwa 2 251 143 424 dalar Amurka. Aimmune Therapeutics, Inc. karfaffen kaya ya kasance zuwa 2 251 143 424 Dalar Amurka a 07/10/2020.

06/10/2020 Aimmune Therapeutics, Inc. capitalization kasuwa daidai yake da 2 250 489 600 dalar Amurka. 05/10/2020 Aimmune Therapeutics, Inc. ikon mallaka daidai yake da 2 247 547 904 dalar Amurka. Aimmune Therapeutics, Inc. capitalization kasuwa shine $ 2 245 913 344 a 02/10/2020.

A capitalization na Aimmune Therapeutics, Inc. a yau shi ne 2 256 700 160 $. Girman kasuwa na Aimmune Therapeutics, Inc. ya canza zuwa +0.12% idan aka kwatanta da jiya. Hanyoyin ciniki na AIMT hannun jari na Aimmune Therapeutics, Inc. a rana ta ƙarshe ta kasuwanci ya kasance 103 658 $. Ƙarin ciniki na Aimmune Therapeutics, Inc. ya canza zuwa -82.983% idan aka kwatanta da ranar ciniki.

Kudin hannun jari Aimmune Therapeutics, Inc.

Finance Aimmune Therapeutics, Inc.